RU99115222A - METHOD FOR TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA - Google Patents

METHOD FOR TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA

Info

Publication number
RU99115222A
RU99115222A RU99115222/14A RU99115222A RU99115222A RU 99115222 A RU99115222 A RU 99115222A RU 99115222/14 A RU99115222/14 A RU 99115222/14A RU 99115222 A RU99115222 A RU 99115222A RU 99115222 A RU99115222 A RU 99115222A
Authority
RU
Russia
Prior art keywords
schizophrenia
resistant patients
therapeutically resistant
treating therapeutically
treating
Prior art date
Application number
RU99115222/14A
Other languages
Russian (ru)
Other versions
RU2177326C2 (en
Inventor
Ольга Анатольевна Никифорова
Тамара Парфеновна Ветлугина
Антонина Григорьевна Перевезнюк
Аркадий Валентинович Семке
Галина Викторовна Логвинович
Original Assignee
Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук
Filing date
Publication date
Application filed by Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук filed Critical Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук
Priority to RU99115222A priority Critical patent/RU2177326C2/en
Priority claimed from RU99115222A external-priority patent/RU2177326C2/en
Publication of RU99115222A publication Critical patent/RU99115222A/en
Application granted granted Critical
Publication of RU2177326C2 publication Critical patent/RU2177326C2/en

Links

Claims (1)

Способ лечения терапевтически резистентных больных шизофренией, включающий одномоментную отмену психотропных средств, отличающийся тем, что на фоне одномоментной отмены психотропных средств вводят иммуномодулирующий препарат тимоген внутримышечно или интраназально по 1 мл 0,01% раствора (100 мкг/мл) ежедневно в течение 5 дней.A method of treating therapeutically resistant patients with schizophrenia, including the simultaneous withdrawal of psychotropic drugs, characterized in that, against the background of the simultaneous withdrawal of psychotropic drugs, an immunomodulating drug thymogen is administered intramuscularly or intranasally in 1 ml of 0.01% solution (100 μg / ml) daily for 5 days.
RU99115222A 1999-07-09 1999-07-09 Method of treating therapeutically resistant patients with schizophrenia RU2177326C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99115222A RU2177326C2 (en) 1999-07-09 1999-07-09 Method of treating therapeutically resistant patients with schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99115222A RU2177326C2 (en) 1999-07-09 1999-07-09 Method of treating therapeutically resistant patients with schizophrenia

Publications (2)

Publication Number Publication Date
RU99115222A true RU99115222A (en) 2001-05-10
RU2177326C2 RU2177326C2 (en) 2001-12-27

Family

ID=20222616

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99115222A RU2177326C2 (en) 1999-07-09 1999-07-09 Method of treating therapeutically resistant patients with schizophrenia

Country Status (1)

Country Link
RU (1) RU2177326C2 (en)

Similar Documents

Publication Publication Date Title
YU84703A (en) Aripiprazole oral solution
PT87542A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL BASED ON INDOLONE DERIVATIVES FOR THE TREATMENT OF THE PARKINSON DISEASE
NZ514574A (en) Novel method of treatment
EE04850B1 (en) Use of pyrimidine derivatives for the preparation of a medicament for the treatment of HIV infection, a compound, a pharmaceutical composition containing it, a process for the preparation of a compound and a composition, and a combination preparation for use in the treatment of HIV infection.
EP0377272A3 (en) Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
IE894048L (en) New therapeutically active compound and a process for its¹preparation
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
HU910177D0 (en) Process for the production of medical preparations for peroral entering of phimobendane
NZ514558A (en) Viral treatment
NO178338C (en) Analogous Process for Preparing a Therapeutically Active Benzimidazole Compound and Intermediate
JP2002522501A5 (en)
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
WO2000048445A3 (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
IL151553A0 (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin
RU99115222A (en) METHOD FOR TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA
KR910015300A (en) Buspyron: Use for the treatment of sleep apnea
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
WO2002017917A8 (en) Manzamines for treatment of drug resistant infection
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
RU97117735A (en) METHOD FOR TREATING DIPHTERIA
RU98103823A (en) METHOD FOR CHANGING A COLLABORATING AND ANTI-COLLISING SYSTEM OF THE ORGANISM
RU2000119692A (en) METHOD FOR TREATING PSORIASIS
RU98109810A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS